Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 143	$ (314)	$ 5,736	$ 2,941
General and administrative	1,709	2,821	6,616	8,775
Merger-related costs	992		2,290
Restructuring and other costs	83		1,723
Loss from operations	(2,927)	(2,507)	(16,365)	(11,716)
Other income (expense):
Interest income	3	16	7	75
Interest expense	(69)		(120)
Change in fair value of warrant liability	30	(258)	528	5,889
Foreign currency exchange gain (loss), net	68	(100)	(67)	(72)
Other expense, net		(22)	(2)	(46)
Total other income (expense), net	32	(364)	346	5,846
Net loss	$ (2,895)	$ (2,871)	$ (16,019)	$ (5,870)
Net loss per share - basic	$ 0	$ 0	$ 0	$ 0
Net loss per share - diluted	$ 0	$ 0	$ 0	$ 0
Weighted-average number of ordinary shares used in computing net loss per share- basic	24,386,005,523	10,116,903,598	18,911,928,794	10,119,421,200
Weighted-average number of ordinary shares used in computing net loss per share - diluted	24,386,005,523	10,116,903,598	18,911,928,794	10,119,421,200
Comprehensive loss:
Net loss	$ (2,895)	$ (2,871)	$ (16,019)	$ (5,870)
Other comprehensive income, net of tax:
Foreign currency translation adjustment	(177)	(3)	114	(58)
Total other comprehensive income, net of tax	(177)	(3)	114	(58)
Total comprehensive loss	$ (3,072)	$ (2,874)	$ (15,905)	$ (5,928)